Recent Updates
Recently added Catalysts
RNXT Positive Sentiment

PharmaShots Webinar: Mastering a Patient-Centric Approach for Treatment in Biopharma

Friday, August 29, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The PharmaShots webinar highlighted the importance of patient-centric approaches in biopharma. Industry leaders and patient advocates discussed strategies to enhance treatment outcomes and bridge the gap between patients and biopharma companies. The session emphasized that prioritizing patients is essential for driving innovation in the industry.
Price reaction · baseline $0.95 (2025-08-29T13:59:00.000Z) · hit during market hours · clean, no other RNXT news in the window
day 0 close · peak
+1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Engagement of industry leaders and patient advocates
  • Focus on patient-centric strategies for innovation
  • Emphasis on improving treatment outcomes and experiences

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+57%
120-day peak, hindsight
Typical move
12.3%
average across 4 past catalysts
Cash runway
~10 mo
Medium dilution risk
Lead asset
nab-paclitaxel
Phase 3 · Locally Advanced Pancreatic Cancer

Full Press Release Details

This insightful session brought together industry leaders and patient advocates to discuss how patient-focused strategies are shaping the future of biopharma.
• T.J. Sharpe – Stage IV Melanoma Survivor & Patient Advocate
• Shaun Bagai – CEO, RenovoRx
• Leesa Gentry – CCO, RenovoRx
• Why patient-centricity is critical for innovation
• Bridging the gap between patients and biopharma companies
• Strategies to create better treatment outcomes & experiences
Watch the full discussion on Youtube

Frequently Asked Questions

What was the focus of the PharmaShots webinar?

The webinar focused on patient-centric strategies in biopharma.

Who were the speakers at the webinar?

Speakers included T.J. Sharpe, Shaun Bagai, and Leesa Gentry.

Why is patient-centricity important in biopharma?

Patient-centricity is critical for driving innovation and improving treatment outcomes.

Where can I watch the full discussion?

The full discussion is available on YouTube.

ShareAdd on Google
Tags: RNXT Viatris Investor Conferences Healthcare patient advocacy biopharma innovation RenovoRx treatment outcomes patient experience
Last updated: Aug 29, 2025

Biotech snapshot

Cash runway
$9M liquidity · $1M/mo burn
~10 mo
Medium dilution risk
Lead asset
nab-paclitaxelPhase 3
Locally Advanced Pancreatic Cancer →

Catalyst track record

+57%
best trade around RNXT's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for RNXT.

See every catalyst's timing & PoA →